Original Research
Published on 04 Aug 2021
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation
in Molecular and Cellular Oncology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.659080
- 5,859 views
- 16 citations
